From Yahoo Finance: 2025-04-17 13:13:00

Merck & Co., Inc. (MRK) is featured as a dirt cheap stock to invest in now. With a Forward P/E Ratio of 8.84 and Earnings Growth of 17.09% this year, it’s attracting attention. The company’s key drug, Keytruda, is performing well with sales reaching $29.5 billion in 2024. Analysts believe in its growth potential.

As the stock market faces volatility, investment strategies are key. Prime Capital Financial CIO Will McGough advises diversification, balancing growth and value stocks for stability. With a shift away from the “Mag Seven,” investors are encouraged to explore Market Weight stocks and international markets for greater opportunities.

For investors looking for dirt cheap stocks, Merck & Co., Inc. (MRK) holds promise. The company’s Animal Health segment shows growth potential, and Keytruda is a key revenue driver. Ranked 3rd on the list, MRK offers potential for growth, but AI stocks may offer higher returns in a shorter timeframe.

Read more: Is Merck & Co., Inc. (MRK) The Dirt Cheap Stock To Invest In Now?